vs
Side-by-side financial comparison of Protalix BioTherapeutics, Inc. (PLX) and SharpLink Gaming, Inc. (SBET). Click either name above to swap in a different company.
SharpLink Gaming, Inc. is the larger business by last-quarter revenue ($10.8M vs $9.1M, roughly 1.2× Protalix BioTherapeutics, Inc.). SharpLink Gaming, Inc. runs the higher net margin — 961.6% vs -60.3%, a 1021.9% gap on every dollar of revenue. On growth, SharpLink Gaming, Inc. posted the faster year-over-year revenue change (1129.9% vs -49.9%). Protalix BioTherapeutics, Inc. produced more free cash flow last quarter ($1.6M vs $-6.3M).
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
Bonne Terre Limited is a British-based gambling company, owned by Flutter Entertainment, with headquarters in Leeds, West Yorkshire and offices in Solihull. Sky Betting & Gaming consists of five core brands: Sky Bet, Sky Vegas, Sky Casino, Sky Poker and Sky Bingo.
PLX vs SBET — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.1M | $10.8M |
| Net Profit | $-5.5M | $104.3M |
| Gross Margin | 49.4% | — |
| Operating Margin | -51.1% | — |
| Net Margin | -60.3% | 961.6% |
| Revenue YoY | -49.9% | 1129.9% |
| Net Profit YoY | -184.8% | 11880.2% |
| EPS (diluted) | $-0.06 | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.1M | — | ||
| Q3 25 | $17.9M | $10.8M | ||
| Q2 25 | $15.7M | $697.3K | ||
| Q1 25 | $10.1M | $741.7K | ||
| Q4 24 | $18.2M | $823.1K | ||
| Q3 24 | $18.0M | $881.7K | ||
| Q2 24 | $13.5M | $981.3K | ||
| Q1 24 | — | $975.9K |
| Q4 25 | $-5.5M | — | ||
| Q3 25 | $2.4M | $104.3M | ||
| Q2 25 | $164.0K | $-103.4M | ||
| Q1 25 | $-3.6M | $-974.9K | ||
| Q4 24 | $6.5M | — | ||
| Q3 24 | $3.2M | $-885.1K | ||
| Q2 24 | $-2.2M | $-463.0K | ||
| Q1 24 | — | $12.4M |
| Q4 25 | 49.4% | — | ||
| Q3 25 | 53.4% | — | ||
| Q2 25 | 62.5% | 30.0% | ||
| Q1 25 | 19.1% | 17.8% | ||
| Q4 24 | 78.7% | 20.2% | ||
| Q3 24 | 53.4% | 19.6% | ||
| Q2 24 | 29.8% | 28.5% | ||
| Q1 24 | — | 29.4% |
| Q4 25 | -51.1% | — | ||
| Q3 25 | 11.9% | — | ||
| Q2 25 | 7.5% | -14826.0% | ||
| Q1 25 | -41.0% | -124.8% | ||
| Q4 24 | 39.6% | — | ||
| Q3 24 | 22.2% | -90.4% | ||
| Q2 24 | -18.0% | -122.8% | ||
| Q1 24 | — | -172.6% |
| Q4 25 | -60.3% | — | ||
| Q3 25 | 13.2% | 961.6% | ||
| Q2 25 | 1.0% | -14832.1% | ||
| Q1 25 | -35.8% | -131.4% | ||
| Q4 24 | 35.6% | — | ||
| Q3 24 | 18.0% | -100.4% | ||
| Q2 24 | -16.4% | -47.2% | ||
| Q1 24 | — | 1265.5% |
| Q4 25 | $-0.06 | — | ||
| Q3 25 | $0.03 | $0.62 | ||
| Q2 25 | $0.00 | $-4.27 | ||
| Q1 25 | $-0.05 | $-1.84 | ||
| Q4 24 | $0.10 | — | ||
| Q3 24 | $0.03 | $-3.02 | ||
| Q2 24 | $-0.03 | $-1.35 | ||
| Q1 24 | — | $40.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $14.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $48.2M | $3.1B |
| Total Assets | $82.3M | $3.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.7M | — | ||
| Q3 25 | $13.6M | — | ||
| Q2 25 | $17.9M | — | ||
| Q1 25 | $19.5M | — | ||
| Q4 24 | $19.8M | — | ||
| Q3 24 | $27.4M | — | ||
| Q2 24 | $23.4M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | — |
| Q4 25 | $48.2M | — | ||
| Q3 25 | $52.9M | $3.1B | ||
| Q2 25 | $49.9M | $452.5M | ||
| Q1 25 | $45.2M | $2.1M | ||
| Q4 24 | $43.2M | $2.1M | ||
| Q3 24 | $32.4M | $2.0M | ||
| Q2 24 | $28.6M | $2.8M | ||
| Q1 24 | — | $2.9M |
| Q4 25 | $82.3M | — | ||
| Q3 25 | $82.3M | $3.1B | ||
| Q2 25 | $78.5M | $453.9M | ||
| Q1 25 | $73.9M | $2.8M | ||
| Q4 24 | $73.4M | $2.6M | ||
| Q3 24 | $61.6M | $2.9M | ||
| Q2 24 | $91.5M | $3.8M | ||
| Q1 24 | — | $5.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.0M | $-6.3M |
| Free Cash FlowOCF − Capex | $1.6M | $-6.3M |
| FCF MarginFCF / Revenue | 17.8% | -57.9% |
| Capex IntensityCapex / Revenue | 4.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | -0.06× |
| TTM Free Cash FlowTrailing 4 quarters | $-13.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.0M | — | ||
| Q3 25 | $-3.7M | $-6.3M | ||
| Q2 25 | $-5.2M | $-1.6M | ||
| Q1 25 | $-5.1M | $-514.1K | ||
| Q4 24 | $4.0M | $-22.8M | ||
| Q3 24 | $4.1M | $-591.2K | ||
| Q2 24 | $-3.6M | $-1.7M | ||
| Q1 24 | — | $-19.3M |
| Q4 25 | $1.6M | — | ||
| Q3 25 | $-4.2M | $-6.3M | ||
| Q2 25 | $-5.7M | — | ||
| Q1 25 | $-5.4M | — | ||
| Q4 24 | $3.6M | $-22.8M | ||
| Q3 24 | $4.0M | — | ||
| Q2 24 | $-3.8M | — | ||
| Q1 24 | — | $-19.3M |
| Q4 25 | 17.8% | — | ||
| Q3 25 | -23.7% | -57.9% | ||
| Q2 25 | -36.2% | — | ||
| Q1 25 | -53.0% | — | ||
| Q4 24 | 19.6% | -2772.0% | ||
| Q3 24 | 22.4% | — | ||
| Q2 24 | -28.1% | — | ||
| Q1 24 | — | -1977.2% |
| Q4 25 | 4.4% | — | ||
| Q3 25 | 2.8% | 0.0% | ||
| Q2 25 | 2.8% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 2.3% | 0.2% | ||
| Q3 24 | 0.5% | 0.0% | ||
| Q2 24 | 1.3% | 0.0% | ||
| Q1 24 | — | 0.2% |
| Q4 25 | — | — | ||
| Q3 25 | -1.58× | -0.06× | ||
| Q2 25 | -31.91× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -1.56× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
SBET
| ETH Staking Segmet | $10.3M | 95% |
| Other | $569.8K | 5% |
